Literature DB >> 24174839

NT-proBNP correlated with strain and strain rate imaging of the right ventricle before and after transcatheter closure of atrial septal defects.

Raghda Ghonimy Elsheikh1, Mohamed Hegab, Andras Szatmari.   

Abstract

BACKGROUND: Atrial septal defects (ASD) account for 10% of all congenital heart lesions and represent the third most congenital cardiac defect seen in adults.
OBJECTIVES: Using strain and strain rate imaging (SRI) to assess right ventricular (RV) function in patients with ASD and correlate the results with the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) before and after transcatheter closure.
METHODS: At the Hungarian Institute of Cardiology, 27 females and 18 males (mean age 21.53 years) were diagnosed with ASD and admitted for percutaneous closure. Echocardiography was done to assess theleft ventricular (LV), RV and left atrial (LA) diameters. For assessment of systolic RV function, we measured Tricuspid annular plane systolic excursion (TAPSE), strain, and SRI. Amplatzer ASD closure was done under general anesthesia. NT-proBNP levels were measured before and three months after closure.
RESULTS: ASD closure was achieved in all patients. The mean ASD diameter was 15.15 mm. The size of the occluder ranged from 10 to 24 mm. The mean LA diameter in the pre-closure group was significantly higher than the control; mean left ventricular end diastolic diameter (LVEDD) showed a non-significant difference from either the control group or the post-closure group, while the mean right ventricular end diastolic diameter (RVEDD) markedly reduced post-closure, and it was significantly higher than the control group. Global RV strain and peak systolic strain rate (PSSR) were significantly higher in ASD group than in the control. The NT-proBNP levels were found to be correlated with pulmonary arterial pressure (PAP), TAPSE, global RV strain and PSSR.
CONCLUSION: Volume overload induced by ASD is associated with increased strain values, which return to normal after closure. NT-proBNP is a parameter which correlates to RV pressure, PAP and the amount of shunt volume caused by an ASD.

Entities:  

Keywords:  Atrial septal defect; NT-proBNP; Right ventricular function; Strain and SRI

Year:  2012        PMID: 24174839      PMCID: PMC3809479          DOI: 10.1016/j.jsha.2012.08.003

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  25 in total

1.  Evaluation of exercise capacity with cardiopulmonary exercise testing and type B natriuretic peptide concentrations in adult patients with patent atrial septal defect.

Authors:  Olga Trojnarska; Andrzej Szyszka; Adrian Gwizdala; Zofia Oko-Sarnowska; Slawomir Katarzynski; Andrzej Siniawski; Ewa Chmara; Andrzej Cieslinski
Journal:  Cardiology       Date:  2006-04-21       Impact factor: 1.869

Review 2.  Non-Doppler two-dimensional strain imaging by echocardiography--from technical considerations to clinical applications.

Authors:  Gila Perk; Paul A Tunick; Itzhak Kronzon
Journal:  J Am Soc Echocardiogr       Date:  2007-03       Impact factor: 5.251

3.  Real-time strain rate imaging of the left ventricle by ultrasound.

Authors:  A Heimdal; A Støylen; H Torp; T Skjaerpe
Journal:  J Am Soc Echocardiogr       Date:  1998-11       Impact factor: 5.251

4.  BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure.

Authors:  J A Grantham; J C Burnett
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

5.  Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients.

Authors:  M Weber; T Dill; A Deetjen; T Neumann; O Ekinci; J Hansel; A Elsaesser; V Mitrovic; C Hamm
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

6.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

Authors:  N Nagaya; T Nishikimi; Y Okano; M Uematsu; T Satoh; S Kyotani; S Kuribayashi; S Hamada; M Kakishita; N Nakanishi; M Takamiya; T Kunieda; H Matsuo; K Kangawa
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

7.  Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect.

Authors:  H Muta; M Ishii; Y Maeno; T Akagi; H Kato
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

8.  Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

Authors:  Hanno H Leuchte; Michael Holzapfel; Rainer A Baumgartner; Isabelle Ding; Claus Neurohr; Michael Vogeser; Tilman Kolbe; Martin Schwaiblmair; Jürgen Behr
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

9.  Atrial natriuretic factor: its (patho)physiological significance in humans.

Authors:  D de Zeeuw; W M Janssen; P E de Jong
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

10.  Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers.

Authors:  P O Collinson; S C Barnes; D C Gaze; G Galasko; A Lahiri; R Senior
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

View more
  3 in total

1.  Assesment of Right Ventricle Function with Speckle Tracking Echocardiography after the Percutaneous Closure of Atrial Septal Defect.

Authors:  Onder Ozturk; Unal Ozturk; Mehmet Zilkif Karahan
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

2.  Changes in Strain Pattern and Exercise Capacity after Transcatheter Closure of Atrial Septal Defects.

Authors:  Jung Yoon Kim; Bong-Sic Yun; Sunho Lee; Se Yong Jung; Jae Young Choi; Nam Kyun Kim
Journal:  Korean Circ J       Date:  2017-03-14       Impact factor: 3.243

3.  Assessment of left ventricular systolic function after VSD transcatheter device closure using speckle tracking echocardiography.

Authors:  Yasmin Abdelrazek Ali; Maryam Araby Hassan; Azza Abdallah El Fiky
Journal:  Egypt Heart J       Date:  2019-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.